Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SRW Ndo1
- Development stage
- Preclinical
- Lead developer
- SRW Laboratories
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
SRW Ndo1 is a multi-ingredient dietary supplement developed by Science Research Wellness (SRW) designed to support healthy blood glucose levels and metabolic function. The formulation is specifically studied for its effects on glycaemia in adults with prediabetes. Its primary active components include Reducose (a standardized white mulberry leaf extract rich in 1-deoxynojirimycin), berberine, and chromium picolinate. Reducose acts as a competitive inhibitor of alpha-glucosidase enzymes in the small intestine, thereby slowing the digestion of complex carbohydrates and reducing postprandial glucose spikes. Berberine contributes by activating AMP-activated protein kinase (AMPK), which enhances insulin sensitivity and cellular glucose uptake, while chromium picolinate supports the action of insulin at the receptor level.
- Brand names
- SRW Ndo1
- Other names
- Science Research Wellness Ndo1Ndo1 Metabolic SupportNdo-1 Metabolic SupportNdo 1 Metabolic Support
02
Targets
Sucrase-IsomaltaseAMPK (Adenosine monophosphate–activated protein kinase)INSR (Insulin receptor)
Beyond the preview
Go deeper on SRW Ndo1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SRW Ndo1.